MedPath

Han Wha Pharma Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus

Phase 2
Conditions
Diabetic Complication
Interventions
First Posted Date
2013-04-19
Last Posted Date
2016-08-17
Lead Sponsor
Han Wha Pharma Co., Ltd.
Target Recruit Count
136
Registration Number
NCT01836172
Locations
🇰🇷

Internal medicine, Seoul National University Hospital, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.